Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Early Multiple Sclerosis
NCT04291456Phase 3Terminated
- Sponsor
- University of Calgary
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in multiple sclerosis (MS), clinically isolated syndrome (CIS), sponsored by University of Calgary. Started Jan 2020; status: terminated.
02
Drugs
minocycline
03
Conditions
multiple sclerosis (MS)clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT04291456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04291456.